Skip to main content
. 2020 May 13;9(5):49. doi: 10.1038/s41389-020-0236-x

Fig. 6. Carbidopa inhibits proliferation of LNCaP cells via AHR.

Fig. 6

a Colony formation assay: LNCaP cells were treated with or without Carbidopa (100 μM). Where indicated, AHR blocker CH223191 was present (10 μM). b TUNEL assay: LNCaP cells were treated with or without Carbidopa (100 μM). Where indicated, AHR blocker CH223191 was present (10 μM). Scale bars = 100 μm. c Quantitative analysis of TUNEL+ cells in at least three separate fields; data are given as means ± SEM. **p < 0.01 versus control. #p < 0.05 versus Carbidopa treatment. d Migration assay: LNCaP cells were treated with or without Carbidopa (100 μM). Where indicated, AHR blocker CH223191 was present (10 μM). Scale bars = 100 μm. e Quantification of the migration assay. Data are given as means ± SEM of three independent experiments. **p < 0.01 versus control. #p < 0.05 versus Carbidopa treatment.